Heads of Units, group and team leaders, and staff scientists form the EMBL Faculty.
EMBL partnerships are close affiliations between EMBL and other prestigious institutions, both local and remote.
EMBL's commercial arm, EMBLEM, facilitates the transfer of innovative technology from basic research to industry.
Key factors behind the non-canonical ZTGC-DNA observed in phages and their successfull transplantation to E. coli
Dariusz Czernecki, Institut Pasteur, Paris11:00 - via Zoom VC
Cryo-EM reveals structures of ESCRT-III membrane remodeling proteins in eukarya and bacteria
Carsten Sachse, Forschungszentrum Juelich10:30 - via Zoom VC
EMBL Ventures manages multi-million euro capital on behalf of private and industrial investors in Europe, including EMBL.